Alzheimer’s disease drugs that target amyloid-β, one of the problematic proteins associated with the disease, may have “no ...

These drugs were hailed by proponents as breakthroughs in the fight to treat Alzheimer’s disease, but a new independent ...

Variants in GLP‑1 and GIP receptor genes partly determine weight loss and nausea risk on GLP‑1 drugs, signaling a shift from ...

The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, ...

Anti-amyloid drugs have been considered game-changing for Alzheimer's, but an extensive review has revealed that the drugs ...

Reproductive symptoms, temperature-related complaints, and psychiatric symptoms are among the side effects of GLP-1s reported ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

Top drugmakers have spent more than a decade investigating and advancing anti-amyloid Alzheimer's medicines in clinical ...

An AI study analyzing more than 400,000 Reddit posts identified patient-reported symptoms associated with GLP-1 medications ...

Using medical marijuana appears to help people reduce the use of other medications, including opioids, sleeping aids and ...

Acosta Group reports GLP-1 users are driving healthier eating, new product demand and labeling challenges, reshaping food, ...